DPX Technologies, a manufacturer of laboratory consumables for sample preparation, continues with business expansion. This expansion includes the development of new product lines for proteomics and genomics testing and the construction of a large storage facility.
As an essential company, DPX continued operating during the pandemic and used this time to focus on product and Intellectual Property development. During 2020, DPX launched a new product and method for automated size exclusion chromatography. The size exclusion chromatography product line positions DPX in the market for proteomics testing, which diversifies their product offerings. DPX also initiated research and development on a new product line for nucleic acid purification and recently obtained a NSF Phase 1 SBIR award to further this research.
The business will continue with their expansion plans by building a large storage facility. The additional square footage is needed to support the increasing demand of inventory for raw materials and finished goods.
“COVID-19 has emphasized the need for fast, automated sample preparation for nucleic acids, and we are committed to providing these solutions,” said William Brewer, CEO of DPX Technologies. “As we continue to expand our product offerings into more market segments for bioanalytical testing, we will be better positioned for long term advancement.” DPX recently hired another molecular biologist, and is purchasing new equipment and instrumentation for nucleic acid analysis. The company has plans to hire additional R&D scientists to support application development for their clients and manufacturing staff.
DPX has been manufacturing pipette tips for sample preparation since 2007 and specializes in developing custom products and workflows for a diverse client base.
About DPX Technologies
DPX is committed to providing innovative sample purification solutions. We collaborate with our customers to provide the high-quality products they need for complex chemical and biological analysis.